This topic contains a solution. Click here to go to the answer

Author Question: How should you prepare to administer adenosine (Adenocard) to a patient with persistent ... (Read 64 times)

cookcarl

  • Hero Member
  • *****
  • Posts: 539
How should you prepare to administer adenosine (Adenocard) to a patient with persistent supraventricular tachycardia (SVT)?
 
  a. Sublingual spray
  b. Rapid IV bolus
  c. Continuous slow infusion
  d. Continuous transdermal patch

Question 2

Which antidysrhythmic drugs may be given by the endotracheal tube route? (select all that apply)
 
  a. Atropine (Atropine Sulfate)
  b. Digoxin (Lanoxin)
  c. Epinephrine (Adrenalin)
  d. Lidocaine (Xylocaine)
  e. Procainamide (Pronestyl)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ErinKing

  • Sr. Member
  • ****
  • Posts: 362
Answer to Question 1

ANS: B

Answer to Question 2

ANS: A, C, D




cookcarl

  • Member
  • Posts: 539
Reply 2 on: Jul 24, 2018
Excellent


mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library